Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Single-cell sequencing reveals transcriptional and metabolic divergence of bone-involved multiple myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

DTDali TongUniversity of Science and Technology of China

Discussion

Loading...

Member takes

Implication

Research demonstrates metabolic differences in multiple myeloma patients with anemia and renal failure, suggesting unique disease profiles.

Key Points

  • This research aims to analyze the transcriptional and metabolic differences in multiple myeloma depending on bone involvement.
  • Employs single-cell sequencing to analyze bone marrow specimens and peripheral blood mononuclear cells from patients.
  • Classifies patients based on presenting symptoms, specifically looking at anemia and renal failure.
  • Utilizes techniques like BCR sequencing, pseudotime analysis, and metabolic profiling to assess differences across patient groups.
  • Identifies distinct metabolic profiles among groups with anemia and renal failure in multiple myeloma patients.
  • Finds variations in immune cell populations related to specific symptoms, indicating immune suppression in certain groups.

Cite This Study

Dali Tong (2025) studied this question.

synapsesocial.com/papers/69362f484fa91c937236d6b8https://doi.org/10.1182/blood-2025-7487
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 6848: Analysis of the bone microenvironment cells by single cell transcriptomics reveals altered features in multiple myeloma patients compared to pre-malignant monoclonal gammopathies2024
  2. 2Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targets2024
  3. 3Altered osteoblast populations dynamics underlie myeloma progression from precursors diseases in bone microenvironment2025
  4. 4Single-cell transcriptomics reveals proliferative, immune-evasive, and bone marrow–independent transcriptional programs in extramedullary multiple myeloma.2025
  5. 5Dissecting the multiple myeloma survival niche to improve novel treatment strategies2025